2Armed Forces Institute of Pathology, Washington, DC 20306-6000 USA Highly mutagenic heterocyclic aromatic amines (HAAs) are formed during frying, broiling, and barbecuing of meat (1) (2) (3) . Metabolic activation, involving N-hydroxylation, is required for HAAs to exert their genotoxic effects (4) . Before adduction to DNA nucleotides, many carcinogens require metabolic activation to reactive species (5) . The N-hydroxy-metabolite of the HAA 2-amino-3-methylimidazo [4,5- fJquinoline (IQ) has been shown to bind directly to DNA at physiological pH (6) .
IQ is a potent carcinogen in rodents and monkeys, inducing tumors at various sites in rats and mice and hepatocellular carcinomas in cynomolgus monkeys (7) (8) (9) (10) .
DNA adducts are generally associated with the initiation of the carcinogenic process by HAAs, but less attention has been given to their possible noncarcinogenic effects. The discovery of high IQ-DNA cardiac adducts by 3 P-postlabeling analysis prompted us to undertake a histological study on hearts from tumor-bearing monkeys chronically dosed with IQ (11) . Preliminary reports of this study have been published in abstract form (12) . The myocardial abnormalities described here closely resemble the early pathological lesions associated with adriamycin (doxorubicin)-induced cardiotoxicity (13) .
Doxorubicin is an anthracycline antibiotic that binds to DNA and induces DNA strand breaks,which have been shown to correlate with its cytotoxic action (14) (15) (16) . Recent in vitro studies of doxorubicin analogues have demonstrated that they complex with DNA resulting in transcriptional blockages (17) . Considering that IQ has been shown to covalently bind to DNA (11) and induce DNA strand breaks in mammalian cells (18) , it is possible that similar mechanisms are involved in the induction of myocardial lesions by IQ and doxorubicin.
Materials and Methods
The two monkey species used in this study were Macaca fascicularis (cynomolgus) and Macaca mulatta (rhesus). They were born in a closed monkey colony located at a contract facility near the National Cancer Institute. As newborns, they remained with their mothers for the first 6 months, until they were weaned. The diet consisted of high protein Purina chow (5045 Standard), vitamin mixture spread on sandwiches, and apples (9) . Dosing with IQ was started at 1 year of age. The monkeys were housed individually in stainless-steel cages in an AAALAC-accredited facility.
Ten tumor bearing monkeys used in this histopathological study were part of a larger carcinogenesis study (10) . They were dosed with IQ at 10 mg/kg or 20 mg/kg five times per week for a period ranging from 48 to 80 months ( cut from the left (epicardial and endocardial halves) and right ventricles, dehydrated in graded alcohol, and embedded in epon for electron microscopy. Onemicron-thick-sections were cut from at least three areas of the left ventricular epicardial and endocardial halves and from the right ventricle. Thin sections for electron microscopy were cut from at least three areas of each sample, stained with uranyl acetate and lead citrate, and examined with a Zeiss 109 microscope. The remainder of the heart was cut transversely from apex to base (five to six slices), immersion-fixed overnight in 10% neutral buffered formalin, and processed for light microscopy. All ventricular slices were embedded in paraffin, cut at 5 pm, and stained with hematoxylin-eosin and Masson trichrome.
Results
Before euthanasia, ECHO-cardiography was carried out on the monkeys dosed with IQ and the HPC treated controls. None of the animals examined exhibited cardiac abnormalities. We performed histopathological analysis on perfusionfixed hearts from 10 monkeys chronically dosed with IQ and two HPC controls. No abnormalities were seen upon gross inspection of the hearts, and the heart weights of all the animals were within normal limits ( Table 1 Table 1 ). For two of the animals, there was correlation between the dosing period and/or the cumulative dose and the extent of myocardial damage (Tables 1-3 ). For example, the animal (case 1) with the highest cumulative dose (91.10 g) had the largest variety of myocardial lesions. Conversely, the animal (case 5) with the lowest cumulative dose (24.58 g) and the shortest dosing period (48 months) had normal myocardi-I | l; iii i i; i Z Zil-iA d i l .9ix-keys in this study (case 1) had numerous primary tumor nodules and metastases (pulmonary), the others had nonmetastatic hepatocellular carcinoma with well-defined tumor nodules ranging in numbers from two to six. All the monkeys dosed with IQ had one or more abnormal findings by light microscopy, electron microscopy, or both. The two control animals that received only HPC, the vehicle for IQ, had normal cardiac morphology.
We detected focal light microscopic lesions in 8 of 10 hearts examined (Table  2) . Multiple histological sections, stained with hematoxylin and eosin or Masson trichrome, were studied from each heart. Scattered foci of interstitial fibrosis, with myocyte hypertrophy and atrophy, were present in the hearts from four animals (cases 1, 3, 9, and 10; Fig. 1 ). The fibrosis was most prominent in the subendocardium. Five animals (cases 1, 3, 7, 9, and 10) had single-cell myocyte necrosis. In four animals (cases 1, 2, 8, and 10), myocyte necrosis was associated with inflammation (lymphocytes and macrophages), but inflammation was also observed without myocyte necrosis (cases 3, 6, 8, and 10), especially adjacent to intramural arterioles (Fig. 2) . One heart (case 6) displayed occasional small foci of interstitial chronic inflammation without associated myocyte necrosis or fibrosis. In two hearts (cases 1 and 2), the walls of scattered arterioles, medium-sized muscular arteries, and veins were infiltrated by mixed acute and chronic inflammatory cells. The hearts from two of the test animals (cases 4 and 5) and the two control animals (cases 11 and 12), had normal histology at the light microscopic level.
We noted ultrastructural lesions in 9 of 10 hearts examined (Table 3) . Examination of the myocardium revealed foci of myofibrillar loss and disorganization of the normal parallel alignment of sarcomeres in seven animals (cases 1, 2, 4, 5, 8, 9, and 10; Fig. 3A-C) . In four of these animals (cases 1, 2, 9 and 10), necrotic myocytes were also present. Mitochondrial abnormalities were a frequent finding in seven of the IQ hearts (cases 1, 2, 3, 7, 8, 9, and 10). These varied from mild to moderate mitochondrial swelling, clearing of normal matrix densities, and disruption of mitochondrial cristae (Fig. 3D and 4) . Amorphous mitochondrial matrix densities were seen in occasional myocytes in one case. Nuclear changes were seen in occasional cells and consisted of hypertrophy and peripheral clumping of the nuclear chromatin. No capillary abnormalities were noted, but increased collagen deposition was present in the interstitium of the subendocardium. In the two animals (cases 4 and 5) with no light microscopic abnormalities, the only electron microscopic findings were myofibrillar loss. Normal ultrastructural architecture was displayed in one of the IQ animals (case 6) and in the two HPC controls (cases 11 and 12; Fig. 5 ).
Discussion
The present findings suggest that chronic exposure to mutagenic dietary HAAs such as IQ can result in myocardial damage in nonhuman primates. The myocardial lesions were focal and not associated with ECHO-cardiographic abnormalities or evidence of congestive heart failure. Light microscopic lesions were detected in 80%
Volume 102, Number 2, February 1994 um by light microscopy and the only electron microscopy finding was focal myofibrillar loss. For the other animals, the cumulative dose correlated better than the dosing period with the myocardial abnormalities. As stated above, all of the monkeys included in this study had malignant liver tumors. Therefore, the myocardial lesions could possibly be secondary to the liver malignancies rather than IQ-mediated damage. Although it cannot be categorically ruled out at this point, it is unlikely that the liver tumors were responsible for the myocardial lesions because the lesions did not correlate with the number or size of the tumor nodules. Only one of the mon- of the perfusion-fixed hearts examined and ultrastructural abnormalities in 90% of the cases. IQ-induced liver pathology has been described elsewhere (9,10), but microscopic evaluation of other organs did not reveal any histopathological findings. The structural myocardial abnormalities found in these macaques chronically dosed with IQ included focal myocyte necrosis, myocardial interstitial fibrosis, myofibrillar loss, and mitochondrial damage. These findings are consistent with the initial stages of toxic cardiomyopathy. A pathologic hallmark of toxic cardiomyopathy is the simultaneous presence of lesions in various stages of evolution (20) . For example, acute myocyte necrosis, inflammation, and myocyte dissolution are seen concurrently with foci of interstitial fibrosis. In five of the monkeys dosed with IQ, myocardial lesions of various stages of development were present, suggestive of a cardiotoxic process. Toxic myocarditis that results in cardiomyopathy is a dose-dependent process and can be expected to be most severe in subjects exposed to the highest dose of the toxic agent (20) . There was some correlation between the extent of myocardial damage and the cumulative dose in the monkeys that received the highest and the lowest dose of IQ, but the length of exposure to IQ correlated less favorably with the extent of cardiotoxicity. Why a dose-response relationship was not more apparent is unknown, but with additional animals and additional dose ranges, such a response may become more distinct.
Statistical analysis was not carried out on the data because the number of animals was small (six in the 10 mg/kg group and four in the 20 mg/kg group), and the myocardial lesions were focal and considered at the initial stages of cardiotoxicity. All the monkeys studied had one or more malignant liver tumor nodules, and one animal had evidence of lung metastasis at the time of autopsy. Although it can be argued that the myocardial lesions observed in the IQ monkeys may be secondary to the malignant liver tumors there was no correlation between the number of the liver tumor nodules or the diameters of individual nodules and the extent of myocardial abnormalities. Further evidence that the myocardial lesions were not secondary to tumor formation comes from studies in rats where IQ was shown to produce cardiotoxicity in cultured myocytes and in vivo (21) .
Various drugs and chemicals have been associated with toxic cardiomyopathy, including anthracycline antibiotics (doxorubicin, daunomycin) (22) (23) (24) (25) , cyclophosphamide (26), azidothymidine (27, 28) , chloroquine (29, 30) , alcohol (31), amphetamines (32) , cocaine (33, 34) , and cobalt Environmental Health Perspectives 196 *** 9. .9* 9 A d * (35) . The pathogenesis of toxic cardiomyopathy varies among different noxious agents. Cardiotoxic drugs and chemicals may act directly on the myocyte and alter myocyte protein synthesis, interfere with mitochondrial function, and/or disrupt cell membrane permeability. Alternatively, the vascular supply of the heart may be the target of toxic agents; vasoactive compounds such as norepinephrine and amphetamine can cause arteriolar vasoconstriction and capillary endothelial damage, resulting in secondary myocyte ischemia and necrosis. High-dose cyclophosphamide therapy has been associated with microthrombi in intramyocardial capillaries (26) . Perhaps the best-characterized example of drug-related toxic cardiomyopathy is anthracycline-induced cardiomyopathy (22) (23) (24) . The most striking pathologic features seen in myocytes is that of mitochondrial damage, vacuolar degeneration (swelling of sarcoplasmic reticulum and Ttubules), and myofibrillar dissolution (20, 23) . The mechanism of anthracyclineinduced cardiomyopathy is uncertain, but may primarily involve direct toxic damage of mitochondria. In ultrastructural studies, mitochondrial swelling, clearing of normal matrix densities, mitochondrial cristae disruption, and mitochondrial degeneration have been described (19) 
